1. Luo D, Qiu X, Zheng Q, Ming Y, Pu W, Ai M, He J, Peng Y*. Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment. J Med Chem. 2024, 67(13):10655-10686.
2. Jin Y, Zuo Y, Li G, Liu W, Pan Y, Fan T, Fu X, Yao X, Peng Y*. Advances in spatial transcriptomics and its applications in cancer research. Mol Cancer. 2024, 23(1):129.
3. Luo C, He J, Yang Y, Wu K, Fu X, Cheng J, Ming Y, Liu W, Peng Y*. SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression. J Cancer Res Clin Oncol. 2024, 150(6):292.
4. Zhou JK, Li J, Peng Y*. circPTPN14 promotes renal fibrosis through its interaction with FUBP1 to enhance MYC transcription. Cell Mol Life Sci. 2023, 80(4):115.
5. Guo J, Peng Y*. A tRF oligomerizes Nucleolin to stabilize metastasis-favoring transcripts. Sci China Life Sci. 2023, 66(3):646-648.
6. Li K, Guo J, Ming Y, Chen S, Zhang T, Ma H, Fu X, Wang J, Liu W, Peng Y*. A circular RNA activated by TGFβ promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability. Nat Commun. 2023, 14(1):6876.
7. Luo W, Zeng Z, Jin Y, Yang L, Fan T, Wang Z, Pan Y, Yang Y, Yao M, Li Y, Xiao X, Wang G, Wang C, Chang S, Che G, Zhang L, Li Y*, Peng Y*, Li W. Distinct immune microenvironment of lung adenocarcinoma in never-smokers from smokers. Cell Rep Med. 2023, 4(6):101078.
8. Chen S, Li K, Guo J, Chen HN, Ming Y, Jin Y, Xu F, Zhang T, Yang Y, Ye Z, Liu W, Ma H, Cheng J, Zhou JK, Li Z, Shen S, Dai L, Zhou ZG, Xu H*, Peng Y*. circNEIL3 inhibits tumor metastasis through recruiting the E3 ubiquitin ligase Nedd4L to degrade YBX1. Proc Natl Acad Sci U S A. 2023, 120(13):e2215132120.
9. Guo J, Zheng Q, Peng Y*. BET proteins: Biological functions and therapeutic interventions. Pharmacol Ther. 2023, 243:108354.
10. Wang C, Liu WR, Tan S, Zhou JK, Xu X, Ming Y, Cheng J, Li J, Zeng Z, Zuo Y, He J, Peng Y*, Li W*. Characterization of distinct circular RNA signatures in solid tumors. Mol Cancer. 2022, 21(1):63.
11. Li J, Zhou JK, Mu X, Shen S, Xu X, Luo Y, Luo Y, Ming Y, Wu Y, Peng Y*. Regulation of XPO5 phosphorylation by PP2A in hepatocellular carcinoma. MedComm. 2022, 3(2): e125.
12. Zuo Y, Zhu L, Guo Z, Liu W, Zhang J, Zeng Z, Wu Q, Cheng J, Fu X, Jin Y, Zhao Y*, Peng Y*. tsRBase: a comprehensive database for expression and function of tsRNAs in multiple species. Nucleic Acids Res. 2021,49(D1):D1038-D1045.
13. Ma R, Lu T, Li Z, Teng KY, Mansour AG, Yu M, Tian L, Xu B, Ma S, Zhang J, Barr T, Peng Y*, Caligiuri MA*, Yu J*. An oncolytic virus expressing IL-15/IL-15Rα combined with off-the-shelf EGFR-CAR NK cells targets glioblastoma. Cancer Res. 2021, 81(13): 3635-3648.
14. He J, Zeng Z, Wang Y, Deng J, Tang X, Liu F, Huang J, Chen H, Liang R, Zan X, Liu Z, Tong A, Guo G, Xu J, Zhu X*, Zhou L*, Peng Y*. Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing. Mol Cancer. 2021, 20(1): 168.
15. Li X, Pu W, Chen S, Peng Y*. Therapeutic targeting of RNA-binding protein by RNA-PROTAC. Mol Ther. 2021, 29(6): 1940-1942.
16. Li J, Zhu L, Cheng J, Peng Y*. Transfer RNA-derived small RNA: A rising star in oncology. Semin Cancer Biol. 2021, 75: 29-37.
17. Huang Z, Zhou JK, Wang K, Chen H, Qin S, Liu J, Luo M, Chen Y, Jiang J, Zhou L, Zhu L, He J, Li J, Pu W, Gong Y, Li J, Ye Q, Dong D, Hu H, Zhou Z, Dai L, Wei YQ, Huang C*, Wei XW*, Peng Y*. PDLIM1 inhibits tumor metastasis through activating Hippo signaling in hepatocellular carcinoma. Hepatology. 2020, 71(5): 1643-1659.
18. Li J, Sun D, Pu W, Wang J, Peng Y*. Circular RNAs in cancer: biogenesis, function, and clinical significance. Trends Cancer. 2020, 6(4): 319-336.
19. Guo Y, Wei X*, Peng Y*. Structure-mediated degradation of circRNAs. Trends Cell Biol. 2020, 30(7): 501-503.
20. Yang X, Ma L, Wei R, Ye T, Zhou J, Wen M, Men R, Aqeilan RI, Peng Y*, Yang L*. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-β pathway. Signal Transduct Target Ther. 2020, 5(1): 75.
22. Pu W, Li J, Peng Y*. Cysteine-113 covalency inspires the development of Pin1 inhibitor. Signal Transduct Target Ther. 2020, (1): 225.
23. Wu K, Liao X, Gong Y, He J, Zhou JK, Tan S, Pu W, Huang C, Wei YQ, Peng Y*. Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer. Mol Cancer. 2019, 18(1): 98.
24. Sun D, Tan S, Xiong Y, Pu W, Li J, Wei W, Huang C, Wei YQ, Peng Y*. MicroRNA biogenesis is enhanced by liposome-encapsulated Pin1 inhibitor in hepatocellular carcinoma. Theranostics. 2019, 9(16): 4704-4716.
25. Zhu L, Li J, Gong Y, Wu Q, Tan S, Sun D, Xu X, Zuo Y, Zhao Y, Wei YQ, Wei XW*, Peng Y*. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019, 18(1): 74.
26. Wang C, Tan S, Liu WR, Lei Q, Qiao W, Wu Y, Liu X, Cheng W, Wei YQ, Peng Y*, Li W*. RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma. Mol Cancer. 2019, 18(1): 134.
27. Liu X, Pu W, He H, Fan X, Zheng Y, Zhou JK, Ma R, He J, Zheng Y, Wu K, Zhao Y, Yang SY, Wang C, Wei YQ, Wei XW*, Peng Y*. Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer. Cancer Lett. 2019, 458: 76-85.
28. Zheng Y, Pu W, Li J, Shen X, Zhou Q, Fan X, Yang SY, Yu Y, Chen Q, Wang C, Wu X, Peng Y*. Discovery of a prenylated flavonol derivative as a Pin1 inhibitor to suppress hepatocellular carcinoma by modulating microRNA biogenesis. Chem Asian J. 2019, 14(1): 130-134.
29. Tan S, Gou Q, Pu W, Guo C, Yang Y, Wu K, Liu Y, Liu L, Wei YQ, Peng Y*. Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer. Cell Res. 2018,28(6):693-695.
30. Pu W, Li J, Zheng Y, Shen X, Fan X, Zhou JK, He J, Deng Y, Liu X, Wang C, Yang S, Chen Q, Liu L, Zhang G, Wei YQ, Peng Y*. Targeting Pin1 by inhibitor API-1 regulates microRNA biogenesis and suppresses hepatocellular carcinoma development. Hepatology. 2018, 68(2): 547-560.
31. Gou Q, Gao L, Nie X, Pu W, Zhu J, Wang Y, Liu X, Tan S, Zhou JK, Gong Y, He J, Wu K, Xie Y, Zhao W, Dai L, Liu L, Xiang R, Wei YQ, Zhang L*, Peng Y*. Long noncoding RNA AB074169 inhibits cell proliferation via modulation of KHSRP-mediated p21 expression in papillary thyroid carcinoma. Cancer Res. 2018, 78(15): 4163-4174.
32. Shu Y, Zhang W, Hou Q, Zhao L, Zhang S, Zhou J, Song X, Zhang Y, Jiang D, Chen X, Wang P, Xia X, Liao F, Yin D, Chen X, Zhou X, Zhang D, Yin S, Yang K, Liu J, Fu L, Zhang L, Wang Y, Zhang J, An Y, Cheng H, Zheng B, Sun H, Zhao Y, Wang Y, Xie D, Ouyang L, Wang P, Zhang W, Qiu M, Fu X, Dai L, He G, Yang H, Cheng W, Yang L, Liu B, Li W, Dong B, Zhou Z, Wei Y, Peng Y*, Xu H*, Hu J*. Prognostic significance of frequent CLDN18-ARHGAP26/6 fusion in gastric signet-ring cell cancer. Nat Commun. 2018, 9(1): 2447.
33. Tan S, Sun D, Pu W, Gou Q, Guo C, Gong Y, Li J, Wei YQ, Liu L*, Zhao Y*, Peng Y*. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. Mol Cancer. 2018, 17(1):138.
34. Li J, Pu W, Sun HL, Zhou JK, Fan X, Zheng Y, He J, Liu X, Xia Z, Liu L, Wei YQ, Peng Y*. Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma. Cell Death Differ. 2018, 25(9): 1612-1624.
35. Li K, Sun D, Gou Q, Ke X, Gong Y, Zuo Y, Zhou JK, Guo C, Xia Z, Liu L, Li Q, Dai L, Peng Y*. Long non-coding RNA linc00460 promotes epithelial-mesenchymal transition and cell migration in lung cancer cells. Cancer Lett. 2018, 420: 80-90.
36. Ma L, Yang X, Wei R, Ye T, Zhou JK, Wen M, Men R, Li P, Dong B, Liu L, Fu X, Xu H, Aqeilan RI, Wei YQ, Yang L*, Peng Y*. MicroRNA-214 promotes hepatic stellate cell activation and liver fibrosis by suppressing Sufu expression. Cell Death Dis. 2018, 9(7): 718.
37. He J, Wu K, Guo C, Zhou JK, Pu W, Deng Y, Zuo Y, Zhao Y, Liu L, Wei YQ, Peng Y*. Long non-coding RNA AFAP1-AS1 plays an oncogenic role in promoting cell migration in non-small cell lung cancer. Cell Mol Life Sci. 2018, 75(24): 4667-4681.
38. Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, Zhang J, Tun N, Peng Y*, Yu J*. Regulation of human natural killer cell IFN-γ production by microRNA-146a via targeting the NF-κB signaling pathway. Front Immunol. 2018, 9: 293.
39. Sun D, Zhou JK, Zhao L, Zheng ZY, Li J, Pu W, Liu S, Liu XS, Liu SJ, Zheng Y*, Zhao Y*, Peng Y*. Novel curcumin liposome modified with hyaluronan targeting CD44 plays an anti-leukemic role in acute myeloid leukemia in vitro and in vivo. ACS Appl Mater Interfaces. 2017, 9(20): 16857-16868.
40. Peng Y*, Croce CM*. The role of microRNAs in human cancer. Signal Transduction and Targeted Therapy. 2016, 1:15004.
41. Sun HL, Cui R, Zhou J, Teng KY, Hsiao YH, Nakanishi K, Fassan M, Luo Z, Shi G, Tili E, Kutay H, Lovat F, Vicentini C, Huang HL, Wang SW, Kim T, Zanesi N, Jeon YJ, Lee TJ, Guh JH, Hung MC, Ghoshal K, Teng CM, Peng Y*, Croce CM*. ERK activation globally downregulates miRNAs through phosphorylating exportin-5. Cancer Cell. 2016, 30(5): 723-736.
42. Peng Y, Dai Y, Hitchcock C, Yang X, Kassis ES, Liu L, Luo Z, Sun HL, Cui R, Wei H, Kim T, Lee TJ, Jeon YJ, Nuovo GJ, Volinia S, He Q, Yu J, Nana-Sinkam P, Croce CM*. Insulin growth factor signaling is regulated by miR-486, an underexpressed microRNA in lung cancer. Proc Natl Acad Sci USA. 2013,110(37):15043-15048.
